This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bergenbio Asa. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Jim Lorens: Innovator in Cancer Detection and Treatment
Introduction
Jim Lorens is a notable inventor based in Bergen, Norway. He has made significant contributions to the field of cancer research, particularly in the detection and treatment of cancer through innovative methods.
Latest Patents
Jim Lorens holds a patent titled "Methods of detecting Akt3 and administering Ax1 inhibitor." This patent discloses the use of Akt3 as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject. Additionally, it describes the use of Akt3 inhibitors to treat cancer. Various methods for detecting the occurrence of EMT in a subject by measuring Akt3 expression and/or activity are also included in this patent. He has 1 patent to his name.
Career Highlights
Jim Lorens is associated with Bergenbio ASA, a company focused on developing innovative cancer therapies. His work has been instrumental in advancing the understanding of cancer biomarkers and treatment options.
Collaborations
One of his notable coworkers is Crina Tiron, who collaborates with him in their research endeavors.
Conclusion
Jim Lorens is a pioneering inventor whose work in cancer detection and treatment continues to impact the medical field. His innovative approaches and dedication to research exemplify the spirit of invention and innovation.